27.04.2016 18:16:00

Big success for the share capital increase reserved for Arkema employees

Regulatory News:

Some 7,400 employees and former employees have subscribed for 998,072 shares, totalling €42.1 million, as a result of a share capital increase operation reserved for Arkema (Paris:AKE) employees, which has just closed. Setting yet another record in terms of monies invested and with a high participation rate, this fifth such operation once again reflects employees’ confidence in the strategy and development of their Group.

Arkema conducted a new share capital increase reserved for employees on 26 April 2016, the fifth such operation since its stock market listing 10 years ago and the first for Bostik employees, who joined the Group in early 2015.

7,430 subscriptions were registered in 26 countries, amounting to €42.1 million. The employee participation rate exceeded that of the last operation proposed in 2014, reaching 67% in France, 21% outside France, or 40% on average, given the relative weight of the Group’s non-French component.

The subscription period spanned 7 to 20 March 2016, with a price of €42.16 per share set by the Board of Directors meeting on 2 March 2016. This price corresponds to the average opening price of the Arkema share quoted on the Paris stock exchange in the last 20 trading days prior to the date of this Board of Directors meeting, minus a 20% discount.

At the close of the operation, 998,072 shares were created, taking the quota of the capital held by employees to a little over 6%.

The newly issued Arkema shares will bear rights from 1st January 2015, with entitlement to dividend payment in 2016.

A designer of materials and innovative solutions, Arkema shapes materials and creates new uses that accelerate customer performance. Our balanced business portfolio spans high-performance materials, industrial specialties and coating solutions. Our globally recognized brands are ranked among the leaders in the markets we serve. Reporting annual sales of €7.7 billion in 2015, we employ approximately 19,000 people worldwide and operate in close to 50 countries. We are committed to active engagement with all our stakeholders. Our research centers in North America, France and Asia concentrate on advances in bio-based products, new energies, water management, electronic solutions, lightweight materials and design, home efficiency and insulation. For the latest, visit www.arkema.com.

Arkema
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex – France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 728 226 950 euros – 445 074 685 RCS Nanterre
arkema.com

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 71,65 0,99% ArkemaAct.